CARCINOMA, RENAL CELL
Clinical trials for CARCINOMA, RENAL CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, RENAL CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, RENAL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New kidney cancer drug shows promise in early safety trial
Disease control CompletedThis early-stage study tested the safety of a drug called belzutifan in 29 adults with advanced clear cell kidney cancer that had worsened after other treatments. The main goal was to see if different doses were safe and tolerable. Researchers monitored side effects and how the d…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
Real-world data confirms combo therapy helps advanced kidney cancer patients live longer
Disease control CompletedThis study looked at how well avelumab (BAVENCIO) plus axitinib (INLYTA) works as the first treatment for people with advanced kidney cancer. Researchers followed 105 patients in Europe to see how many were alive after 12 months and how the treatment affected their cancer. The go…
Matched conditions: CARCINOMA, RENAL CELL
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
Immunotherapy combo before kidney surgery shows promise in small trial
Disease control CompletedThis early-phase study tested two immunotherapy drugs (spartalizumab and canakinumab) given before surgery to 17 people with localized kidney cancer. The main goal was to see if the combination was safe and did not delay surgery. Researchers also looked at how the drugs affected …
Matched conditions: CARCINOMA, RENAL CELL
Phase: EARLY_PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
New drug combo shows promise in early cancer trial
Disease control CompletedThis early-phase study tested a combination of two drugs, axitinib and everolimus, in 19 adults with advanced solid tumors, especially kidney cancer. The main goal was to find the safest dose by monitoring side effects. Participants had already tried other treatments or could not…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
Can a simple biomarker tell which cancer therapy will work?
Knowledge-focused CompletedThis study looked at whether a new biomarker called 'mass response' can help predict how well cancer treatments will work. Researchers collected tumor cells from 72 adults with various cancers using fluid samples or biopsies. The goal was to see if this biomarker could guide ther…
Matched conditions: CARCINOMA, RENAL CELL
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC